Back

Polypharmacy and major adverse events in atrial fibrillation

23 April 2021 (00:00 - 00:00)
Organised by:
Congress Presentation Part of: Optimal therapy of atrial fibrillation Rhythm Control, Antiarrhythmic Drugs EHRA Premium Access EHRA 2021

About the speaker

Photo
Doctor Andreas Papazoglou

Naval Hospital of Athens, Athens (Greece)

7 More presentations in this session

Presentation thumbnail
Achieving acute mitral isthmus block with catheter ablation with vein of marshall ethanol infusion
Doctor M. Andronache (Clermont-Ferrand, FR)
Abstract Slides Video
Presentation thumbnail
Bleeding risk and healthcare resource utilisation in elderly patients treated with edoxaban or vitamin K antagonists for atrial fibrillation in Italy
Ms E. Smits (Utrecht, NL)
Abstract Slides Video
Presentation thumbnail
Antiarrhythmic drug responders among patients with recurrent atrial fibrillation after catheter ablation
Doctor Y. Park (Daegu, KR)
Abstract Slides Video
Presentation thumbnail
Esophagus-to-posterior Atrial wall relationship: pre- and Intra-procedural three-dimensional multimodality imaging for esophageal position.
Doctor C. Teres (Lausanne, CH)
Abstract Slides Video
Presentation thumbnail
The magnitude and the course of local impedance drop to guide successful AF ablation: insight from an Italian registry
Doctor V. Schillaci (Mercogliano, IT)
Abstract Slides Video

Access the full session

Session thumbnail
Optimal therapy of atrial fibrillation

The Event

Event poster

EHRA 2021

23 April - 25 April 2021

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources